Drug-Induced Liver Disease
|
0.310 |
Biomarker
|
phenotype |
BEFREE |
Based on these results, 213 DILI patients from all over the Chinese mainland were further recruited to investigate possible association between UGT1A9 and DILI.
|
25446781 |
2015 |
Drug-Induced Liver Disease
|
0.310 |
Biomarker
|
phenotype |
CTD_human |
Phenotypic and genotypic assessment of concomitant drug-induced toxic effects in liver, kidney and blood.
|
20623750 |
2011 |
Hepatitis, Toxic
|
0.300 |
Biomarker
|
disease |
CTD_human |
Phenotypic and genotypic assessment of concomitant drug-induced toxic effects in liver, kidney and blood.
|
20623750 |
2011 |
Kidney Failure, Acute
|
0.300 |
Biomarker
|
disease |
CTD_human |
Phenotypic and genotypic assessment of concomitant drug-induced toxic effects in liver, kidney and blood.
|
20623750 |
2011 |
Hepatitis, Drug-Induced
|
0.300 |
Biomarker
|
disease |
CTD_human |
Phenotypic and genotypic assessment of concomitant drug-induced toxic effects in liver, kidney and blood.
|
20623750 |
2011 |
Acute Kidney Insufficiency
|
0.300 |
Biomarker
|
disease |
CTD_human |
Phenotypic and genotypic assessment of concomitant drug-induced toxic effects in liver, kidney and blood.
|
20623750 |
2011 |
Acute kidney injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
Phenotypic and genotypic assessment of concomitant drug-induced toxic effects in liver, kidney and blood.
|
20623750 |
2011 |
Drug-Induced Acute Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
Phenotypic and genotypic assessment of concomitant drug-induced toxic effects in liver, kidney and blood.
|
20623750 |
2011 |
Chemical and Drug Induced Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
Phenotypic and genotypic assessment of concomitant drug-induced toxic effects in liver, kidney and blood.
|
20623750 |
2011 |
Chemically-Induced Liver Toxicity
|
0.300 |
Biomarker
|
disease |
CTD_human |
Phenotypic and genotypic assessment of concomitant drug-induced toxic effects in liver, kidney and blood.
|
20623750 |
2011 |
Malignant neoplasm of breast
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Crigler Najjar syndrome, type 1
|
0.180 |
GeneticVariation
|
disease |
CLINVAR |
Two Different UGT1A1 Mutations causing Crigler-Najjar Syndrome types I and II in an Iranian Family.
|
26697581 |
2015 |
Crigler Najjar syndrome, type 1
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
Now, examination of the UGT1 gene structure in hyperbilirubinemic patients has revealed more than 100 different genetic defects in Crigler-Najjar syndromes and one genetic alternation that accounts for the majority of Gilbert's syndrome cases.
|
19845429 |
2010 |
Crigler Najjar syndrome, type 1
|
0.180 |
AlteredExpression
|
disease |
BEFREE |
The result of extreme unconjugated bilirubin in Ugt1(-/-) mice, comparable to the induced levels noted in patients with Crigler-Najjar type 1 disease, is fatal in neonatal Ugt1(-/-) mice within 2 weeks following birth.
|
18180294 |
2008 |
Crigler Najjar syndrome, type 1
|
0.180 |
GeneticVariation
|
disease |
CLINVAR |
Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation.
|
15712364 |
2005 |
Crigler Najjar syndrome, type 1
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
As we had previously shown that CN-I was, in Tunisia, associated with homozygosity for the Q357R mutation within the UGT1 gene, we were able to detect this mutation in both families and to show that it was easily recognized by single-strand conformation polymorphism (SSCP) analysis.
|
12378576 |
2002 |
Crigler Najjar syndrome, type 1
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
Lesions in the gene encoding bilirubin-UGT(1), lead to complete or partial inactivation of the enzyme causing the rare autosomal recessively inherited conditions, Crigler-Najjar syndrome type-1 (CN-1) and type 2 (CN-2), respectively.
|
11013440 |
2000 |
Crigler Najjar syndrome, type 1
|
0.180 |
GeneticVariation
|
disease |
CLINVAR |
Crigler-Najjar syndrome type II resulting from three different mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.
|
11182932 |
2000 |
Crigler Najjar syndrome, type 1
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
This study reports the molecular characterisation of the bilirubin UDP-glucuronosyl-transferase gene (UGT1) in a group of patients of Sardinian descent with Crigler-Najjar syndrome type I and their relatives.
|
9039987 |
1997 |
Crigler Najjar syndrome, type 1
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
The most severe syndrome, termed Crigler-Najjar syndrome type I, is mainly associated with mutations in exons 2 to 5 that affect all UGT1 enzymes and many of the mutations result in termination codons and frameshifts.
|
9435989 |
1997 |
Crigler Najjar syndrome, type 1
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
Genetic and biochemical criteria are required to link CN-I with mutations in UGT1.
|
7906695 |
1994 |
Crigler Najjar syndrome, type 1
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
Here, we report eleven mutations (including nine novel mutations) of the B-UGT1 gene in a large series of 14 unrelated CN-I children of various geographic origins: France (seven patients: A401P, Q357X, W335X, A368T, 1223insG, A291V, K426E, K437X); Portugal (two patients: G308E); Tunisia (two patients; Q357R); Turkey (one patient: S381R); italy (two siblings: S381R).
|
7989045 |
1994 |
Crigler Najjar syndrome, type 1
|
0.180 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Gilbert Disease (disorder)
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
Now, examination of the UGT1 gene structure in hyperbilirubinemic patients has revealed more than 100 different genetic defects in Crigler-Najjar syndromes and one genetic alternation that accounts for the majority of Gilbert's syndrome cases.
|
19845429 |
2010 |
Gilbert Disease (disorder)
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
Because the most common clinical condition associated with jaundice in adults is Gilbert's syndrome, which is characterized by an allelic polymorphism in the UGT1A1 promoter, hyperbilirubinemia was monitored in humanized UGT1 mice that expressed either the Gilbert's UGT1A1*28 allele [Tg(UGT1(A1*28))Ugt1(-/-) mice] or the normal UGT1A1*1 allele [Tg(UGT1(A1*1))Ugt1(-/-) mice].
|
20194756 |
2010 |